期刊文献+

小儿肺动脉高压的药物治疗进展 被引量:2

原文传递
导出
摘要 肺动脉高压发病率在小儿相对常见,主要发生在小儿先天性心脏病中。近几年来,随着一些新药的应用,治疗上已有了显著地改善[1]。肺动脉高压传统的定义(2003WHO)是海平面标准大气压下,
出处 《中国药物经济学》 2012年第2期15-17,共3页 China Journal of Pharmaceutical Economics
基金 温州医学院2010浙江省大学生科技创新活动计划项目(新苗人才计划)资助项目(项目编号:2010R413046)
  • 相关文献

参考文献9

  • 1Astrid E Lammers, Alison A Hislop, Yvette Flynn, et al. Epoprostenol treatment in children with severe pulmonary hypertension. Heart 2007;93:739-743.
  • 2Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J (2009) 30(20):2493-2537.
  • 3Humbert M, Sitbon O, Simonneau G..Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-1436.
  • 4Haworth SG Flynn Y, Hislop AA. Survival and quality of life in children with severe pulmonary hypertension. Heart 2006;92(Supple II):A14.
  • 5The International Primary Pulmonary Hypertension Study Group (1994) The international primary pulmonary hypertension study (IPPHS). Chest 105:37S-41S.
  • 6ManesA, Galie N, Palazzini M, et al. Reverse remodelling ofECG changes in idiopathic PAH patients responders to chronic treatment with calcium channel blockers. Eur Heart J (2006) 27:114.
  • 7van Loon RL, Hoendermis ES, Duffels MG et al. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? Am Heart J. 2007 Oct;154(4):776-82.
  • 8Gali6 N, Negro L, Simonneau G.The use of combination therapy in pulmonary arterial hypertension:new developments.Eur Respir Rev 2009; 18:148-153.
  • 9S Maiya,AA Hislop,Y Flynn,et al.Response to bosentan in children with pulmonary hypertension Heart 2006;92:664-670.

同被引文献37

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部